Eden Evins, MD, MPH, is the Founding Director and Principal Investigator in the Center for Addiction Medicine and the Cox Family Professor of Psychiatry in the Field of Addiction Medicine at Harvard Medical School. Her research has focused on of the efficacy of pharmacotherapeutic cessation aids in smokers with and without serious mental illness, and on the effect of nicotine on cognitive performance in those with and without schizophrenia. A newer line of investigation explores the effect of cannabis on psychiatric symptoms, cognitive function, and addictive behaviors.
-
This study supports the use of a contingency management intervention as a potentially viable harm reduction strategy for adolescents and young adults not yet ready […] -
Suicidal Thoughts, Psychiatric Symptoms Increased in Adolescents Using Alcohol, Cannabis or NicotinePublished in JAMA Pediatrics, this survey-based study sheds light on the link between substance use and mental health issues among high school students. -
In individuals with serious mental illness, an 18-month intervention with first-line pharmacotherapy and tailored behavioral support for smoking cessation and weight management is effective for […] -
While most adults had a stable pattern of use over the first year, about 13% of the participants in this study had an escalating pattern […] -
Cannabis use disorder symptoms are more common in adults receiving medical cannabis cards, especially in those with anxiety or depressive symptoms. -
Four weeks of incentivized cannabis abstinence among adolescents and young adults was associated with an increase in both the frequency and amount of alcohol used.